Skip to content

Type: Peer Reviewed Publications

Peer Review | Incorporating Patient Advocates in Oncology Clinical Development: Lessons Learned From a Novel Pilot Program

Peer Review | The Value of Addressing Patient Preferences

Abstract Recent scientific progress is, in some cases, leading to transformative new medicines for diseases that previously had marginal or even no treatment options. This offers great promise for people affected by these diseases, but it has also placed stress on the health care system in terms of the growing cost associated with some new interventions. Effort has been taken to…

Peer Review | Use of FDA-Approved and Laboratory-Developed Tests in Advanced Non-Small Cell Lung Cancer: Results of a Retrospective Market Analysis

Peer Review | Commentary: Tackling the Challenges of Developing Targeted Therapies for Cancer

Peer Review | Achieving the goals of effective, safe, and individualized cancer care.

Peer Review | Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe.

Peer Review | Reducing the toxicity of cancer therapy: recognizing needs, taking action.

Peer Review | Considerations for the successful co-development of targeted cancer therapies and companion diagnostics.

Peer Review | Use of multiple endpoints and approval paths depicts a decade of FDA oncology drug approvals.

Peer Review | Developing standards for breakthrough therapy designation in oncology.